tiprankstipranks
Trending News
More News >
Lipella Pharmaceuticals, Inc. (LIPO)
NASDAQ:LIPO
US Market

Lipella Pharmaceuticals, Inc. (LIPO) Income Statement

Compare
111 Followers

Lipella Pharmaceuticals, Inc. Income Statement

Last quarter (Q3 2024), Lipella Pharmaceuticals, Inc.'s total revenue was $80.38K, a decrease of -99.92% from the same quarter last year. In Q3, Lipella Pharmaceuticals, Inc.'s net income was $-1.44M. See Lipella Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 536.36M$ 449.62K$ 184.16K$ 259.35K$ 961.68K
Gross Profit
$ 536.36M$ -2.59M$ -2.36M$ -1.20M$ -14.28K
Operating Expenses
$ 5.62B$ 2.16M$ 2.77M$ 2.18M$ 1.02M
Depreciation and Amortization
$ 0.00$ 1.69K$ 2.59M$ 1.92M$ 56.86K
EBITDA
$ -5.08B$ -4.61M$ -2.59M$ 0.00$ -53.69K
Operating Income
$ -5.08B$ -4.75M$ -2.59M$ -1.92M$ -56.86K
Other Income/Expenses
$ 64.28M$ 126.99K$ -7.98K$ 50.35K$ -4.79K
Pretax Income
$ -5.02B$ -4.62M$ -2.60M$ -1.87M$ -61.66K
Net Income
$ -5.02B$ -4.62M$ -2.60M$ -1.87M$ -66.45K
Per Share Metrics
Basic EPS
$ -4.79K$ -6.16$ -0.45$ -0.33$ -0.01
Diluted EPS
$ -4.79K$ -6.16$ -0.45$ -0.33$ -0.01
Weighted Average Shares Outstanding
1.05M 749.83K 5.74M 5.74M 5.69M
Weighted Average Shares Outstanding (Diluted)
1.05M 750.38K 5.74M 5.74M 5.69M
Currency in USD

Lipella Pharmaceuticals, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis